Bolus Injectors Contribute Largest Revenue to Global Wearable Injectors Market

The global wearable injectors market is likely to grow from $2,162.1 million in 2015 to $13.0 billion by 2024. With the explosive growth of bolus injectors and increasing interest of pharmaceutical companies in collaborating with device manufacturers for drug device combination, the market for wearable injectors is expected to show dramatic rise. The launch of bolus injector expands the usage of wearable injectors from diabetes to other disease segments, as the wearable injectors currently available in market are majorly insulin pumps. The growing need for continuous and subcutaneous drug delivery has developed the demand for wearable injectors among the patients.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/wearable-injectors-market/report-sample

Cancer is expected to be the largest application area of wearable injectors. According to the analyst, cancer and autoimmune disease are expected to be the major application areas for wearable injectors in the near future. The other key applications of wearable injectors include infectious disease, cardiovascular disease and blood disorders. Also, homecare is expected to be the largest end user of wearable injectors.

Growing need for advanced drug delivery is one of the major factors driving the growth of the global wearable injectors market. Increasing demand for homecare and advanced drug delivery requiring minimal expertise and lesser hospitalization of patients is expected to drive the demand for wearable injectors, globally. Also, many biopharmaceutical companies have been looking for a better mode of drug delivery for their portfolio of biologic drugs, for which wearable injectors are an appropriate solution.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/wearable-injectors-market

Increasing need for better patient care is creating ample growth opportunities for the global market. Electronic wearable injectors create yet another opportunity for the global market, as these types of wearable injectors are technically more advanced, do not require patient training and are easy to use. As compared to these, mechanical wearable injectors are self-administration devices that require one time administration of the drugs, manually, by the patient. Mechanical wearable injectors are either pre-loaded or loaded at the time of administration.

The research states that the global wearable injectors market had a consolidated structure in 2015, where the top three competitors accounted for the major share in the global wearable injectors market. Some of the key players operating in the global market are Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, CeQur SA, Enable Injections, ScPharmaceuticals, Inc., SteadyMed Ltd., Ypsomed Group, West Pharmaceutical Services, Inc. and Canè S.p.A.

Weight Management Market Size, Share, Growth and Forecast to 2023

The global weight management market is growing significantly due to escalating technological advancement, increasing innovation in weight management ingredients, and increasing prevalence of obesity. According to National Health and Nutrition Examination Survey (NHANES) in 2009-10, more than 78 million U.S. adults were obese. Similarly, as per World Health Organization (WHO), approximately 2.8 million people die each year due to obesity.

Explore more or request TOC on “Global Weight Management Market” at: https://www.psmarketresearch.com/market-analysis/weight-management-market

Massive unexplored market in weight management industry and increasing medical tourism in developing economies are creating ample opportunities for the weight management market to grow at a considerable rate during the forecasted period. In addition, the advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the weight management industry.

The weight management market is categorized on the basis of diet and equipment. On the basis of diet, the market can be categorized as meals, supplements, and beverages. Diet leads the market due to increasing prevalence of obese cases, technological advancement and increasing health consciousness of people. The meals can be further segmented as meal replacement, organic food and others; whereas, supplements can be segmented as protein, fiber and others.

Geographically, North America will be leading the global weight management market in the coming years, due to increasing prevalence of obesity, increase in childhood obesity, strong government support and funding, and change in lifestyle and junk food habits. In addition, increasing membership of health clubs and technological advancement are also driving the growth of the market in North America. Asia-Pacific is the fastest growing region in the global weight management market. The major reasons for the fastest growth of weight management market in the region are increasing medical tourism, large pool of patients, and increasing healthcare expenditure. Moreover, the weight management market is growing due to increasing awareness of weight management, and refining healthcare infrastructure in the emerging countries, such as India and China, of Asia-Pacific region.


Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/weight-management-market/report-sample

Some of the companies operating in the global weight management market are Amer Sports, Technogym SPA, Weight Watchers International Inc., Ediets.Com Inc., Jenny Craig Inc., Medtronic Inc., Kellogg Company, Brunswick Corporation, Jenny Craig Inc., Atkins Nutritionals Inc., Herbalife Ltd., Apollo Endosurgery Inc., Nutrisystem Inc., Cyber International, Inc., and Johnson & Johnson.

Cardiac Bio-Implant Devices Market Size, Analysis, Growth and Future Scope

The global cardiac bio-implant devices market is witnessing growth due to high incidences of cardiovascular diseases and increasing geriatric population. The massive unexplored cardiac bio-implant devices market in the emerging economies is creating ample opportunities for the growth of the global cardiac bio implant devices market, at a considerable rate in the coming years. The advanced research and development activities and new product developments by the major players are supporting the demand for cost effective and efficient cardiac bio-implant devices, thus fuelling the growth of the global cardiac bio-implant devices market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/cardiac-bio-implant-devices-market

Cardiovascular disease refers to the disease of heart or blood vessels, which are mainly caused due to blood clot or cholesterol deposit inside an artery. Cardiovascular diseases are of several types including coronary heart disease, rheumatic heart disease, peripheral arterial disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism. Some of the major risk-leading habits towards cardiovascular diseases are high blood pressure, high blood cholesterol, diabetes, smoking and obesity. Moreover, alcohol, lack of exercise and poor nutrition may also cause heart diseases. According to the WHO, cardiovascular diseases are the major cause of all deaths worldwide. The organization also reported that 17.5 million people died from cardiovascular diseases in 2012, representing 31% of all deaths globally. 

Geographically, North America leads the global cardiac bio-implant devices market due to high healthcare expenditure, aging population and high prevalence of cardiovascular diseases. In addition, the technological advancement and high investment by major players for the development of cardiac bio-implant devices are fueling the growth of the cardiac bio-implant devices market in North America. Asia-Pacific is the fastest growing region in the global cardiac bio-implant devices market, driven by improving healthcare infrastructure, growing healthcare expenditure and high prevalence of cardiovascular diseases. Moreover, the Asia-Pacific cardiac bio-implant devices market is growing rapidly due increasing research and development activities and increasing awareness about cardiac bio-implant devices among patients and healthcare providers in emerging economies, such as India and China.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/cardiac-bio-implant-devices-market/report-sample

The key players operating in the global cardiac bio-implant devices market are St. Jude Medical Inc., Medtronic, Boston Scientific Corporation, Johnson & Johnson Services Inc., Sorin Group, Abbott and Edwards Lifesciences Corporation.

Clot Management Devices Market - Drivers, Restraints, Opportunities, and Challenges

The global clot management devices market is growing significantly due to large geriatric population and high incidences of cardiovascular diseases, such as stroke and heart attacks. The increasing demand for minimally invasive surgeries and massive unexplored clot management devices market in the emerging economies are creating ample opportunities for the growth of the global clot management devices market. The advanced research and development facilities and new product developments by the major players are supporting the demand for cost-effective and efficient clot management devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/clot-management-devices-market

In the global clot management devices market, a trend of increasing usage of percutaneous procedures for clot management has been observed. Clot management refers to the treatment of patients with blood clots, such as pulmonary embolism, arterial blood clots and deep vein thrombosis. Blood clot or thrombus is formed by platelets and fibrin in blood to stop bleeding from injured blood vessels. However, sometimes a blood clot is formed inside a blood vessel even though when it is not required. This may lead to serious medical consequences, such as deep vein thrombosis and pulmonary embolism. There are several risk-leading factors, such as smoking, certain surgeries, inherited blood clotting diseases, pregnancy, immobility, high cholesterol level and certain heart diseases, which may cause blood clots.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/clot-management-devices-market/report-sample

The key players operating in the global clot management devices market are Applied Medical Resources Corporation, EKOS Corporation (a BTG International group company), St. Jude Medical Inc., Medtronic, Boston Scientific Corporation, Volcano Corporation, AngioDynamics, Johnson & Johnson Services Inc., Sorin Group, Bayer AG, Abbott, Stryker and Edwards Lifesciences Corporation.

Single-Use Bioprocessing Systems Market Trends, Size, Growth and Forecast to 2023

Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems market. In addition, technological advancement in bioprocessing systems is also driving the growth of global single-use bio-processing systems market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends, observed in the global single-use bioprocessing systems market.

Explore more or request TOC on “Global Single-Use Bioprocessing Systems Market” at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market

Single-use bioprocessing technology is mainly used in the development and production of biopharmaceuticals. The technology is used throughout the workflow of biopharmaceutical production, starting from buffer and media preparation to bioreactor cultures for vaccines to the storage and shipping of intermediates and bulk biologics. Single-use bio-processing techniques are carried out through several products. Some of the major products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, outer support containers, and single-use mixers. These products reduce cost related to the complex bioproduction procedures, such as cleaning, sterilization, and care of the large bioreactors. 

Europe and North America are the major markets for single-use bioprocessing systems, attributed to the increased life science research and growing demand for biopharmaceuticals. Asia-Pacific market for the single-use bioprocessing systems is growing at a significant rate owing to improving life science infrastructure and increasing investment by several pharmaceutical manufacturing companies for the development of R&D plants in the region. Apart from these regions, Latin America and Middle-East are other important markets of single-use bio-processing systems.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market/report-sample

Country wise, the U.S., followed by Canada, is the largest market for single-use bioprocessing systems in North America. Germany, the U.K., France and Italy are some of the major countries holding significant shares of single-use bio-processing systems market in Europe. In Asia-Pacific, India, Japan, and China are major markets for single-use bio-processing systems; whereas Brazil holds largest market share of single-use bioprocessing systems market in Rest of the World (RoW).

Browse related market research at: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the major players operating in global single-use bioprocessing systems market include Tarpon Biosystems Inc., GE Healthcare, STI Components Inc., Merck & Co Inc., Saint-Gobain Corporation, Sartorius Stedim Biotech SA, PendoTECH, ThermoFisher Scientific Inc., Parker Hannifin Corporation, Pall Corporation, Eppendorf AG, Cellexus Ltd. and Broadley-James Ltd.

Single-Use Bioprocessing Systems Market Size, Drivers, Trends, Challenges & Forecast, 2023

Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems market. In addition, technological advancement in bioprocessing systems is also driving the growth of global single-use bio-processing systems market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends, observed in the global single-use bioprocessing systems market.

Explore more or request TOC on “Global Single-Use Bioprocessing Systems Market” at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market

Single-use bioprocessing technology is mainly used in the development and production of biopharmaceuticals. The technology is used throughout the workflow of biopharmaceutical production, starting from buffer and media preparation to bioreactor cultures for vaccines to the storage and shipping of intermediates and bulk biologics. Single-use bio-processing techniques are carried out through several products. Some of the major products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, outer support containers, and single-use mixers. These products reduce cost related to the complex bioproduction procedures, such as cleaning, sterilization, and care of the large bioreactors. 

Stringent regulations for the implementation of disposable systems and problems associated with the usage of plastic-based disposable products are some of the common factors restraining the growth of the single-use bioprocessing systems market. Moreover, lack of awareness towards innovative applications of disposables in bioproduction is also hindering the growth of the single-use bioprocessing systems market. However, countries, such as China and India are witness a considerable growth during the forecast period due to improving life science research infrastructure.

Request For Table of Content at: https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market/toc-sample

Some of the major players operating in global single-use bioprocessing systems market include Tarpon Biosystems Inc., GE Healthcare, STI Components Inc., Merck & Co Inc., Saint-Gobain Corporation, Sartorius Stedim Biotech SA, PendoTECH, ThermoFisher Scientific Inc., Parker Hannifin Corporation, Pall Corporation, Eppendorf AG, Cellexus Ltd. and Broadley-James Ltd.

Fluoroscopy and Mobile C-arms Market Size, Analysis, Drivers, Trends, Challenges & Forecast

Growing geriatric population and increasing number of sports injuries worldwide are some of the predominant growth drivers of the fluoroscopy and mobile C arms market. For instance, in the U.S., about 30 million children and teens participate in various types of sports every year. This participation resulted in significant rise in sports-related injuries in the country. Moreover, technological advancement in fluoroscopy and mobile C-arms equipment, improving healthcare infrastructure and rising number of interventional radiology surgeries are also driving the growth of global fluoroscopy and mobile C-arms market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends witnessed in the global fluoroscopy and mobile C-arms market. While the fluoroscopy devices hold larger share in the global fluoroscopy and mobile C-arms market, and the mobile C-arm is the faster growing segment in terms of volume.

Explore Report at: https://www.psmarketresearch.com/market-analysis/fluoroscopy-and-mobile-c-arms-market

Fluoroscopy and mobile C-arms are medical imaging techniques used in variety of diagnostic and therapeutic procedures. Fluoroscopy provides X-ray imaging that is especially useful to examine the internal structure and functions of patient’s body. It is the most commonly used in image-guided surgeries, general radiology and interventional radiology.

The mobile C-arm equipment is also based on X-ray technology and frequently used in vascular surgeries, traumatology, cardiology, and orthopedics. The name “mobile C-arm” is derived from the C-shaped arm used to connect the X-ray source and X-ray detector to one another. Mobile C-arms are mainly categorized into two types – full size C-arms and mini C-arms. The full size C-arms is the faster growing segment in the global fluoroscopy and mobile C-arm market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/fluoroscopy-and-mobile-c-arms-market/report-sample

By country, Germany, U.K., France, and Italy are some of the major countries holding significant share of fluoroscopy and mobile C-arms market in Europe. In North America, the U.S, followed by Canada, is the largest market for the fluoroscopy and mobile C-arms market. In Asia-Pacific, India, Japan, and China are the major markets for fluoroscopy and mobile C-arms. The Asia-Pacific market is expected to witness the fastest growth, attributed to the increasing healthcare expenditure and presence of large pool of patients. Whereas, Brazil holds largest market share of fluoroscopy and mobile C-arms market in Latin America.

Some of the major players operating in global fluoroscopy and mobile C-arms market include, Ziehm Imaging GmbH, Toshiba Medical Systems Corporation, Siemens Healthcare GmbH, Shimadzu Corporation, Koninklijke Philips N.V., OrthoScan, Inc., Hologic, Inc. and GE Healthcare.